News

EVERSANA, a leading provider of global commercial services to the life sciences industry, has announced two strategic ...
Individuals with recall related inquiries can contact Amneal Pharmaceuticals at (833) 582-0812 or via email at sulfamethoxazole-trimethoprim-recall@amneal.com. Adverse reactions should be reported to ...
Experts say the gonorrhoea figures are a worry. although the actual number of drug-resistant cases is low. Antibiotics are overused by some and out of reach for others - fuelling resistance and ...
The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).
The agency set aside concerns about UroGen’s approval trial to greenlight mitomycin intravesical solution for recurrent non-muscle invasive bladder cancer.